Business · 16/07/2026
Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
The National Cancer Institute (NCI) is seeking research co-development partners and/or licensees to develop papilloma-infiltrating lymphocytes (PIL) as a treatment for patients with chronic HPV 6 or 11 infections.